Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
about
Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review.Clinical Use of Cinacalcet in MEN1 HyperparathyroidismCare for patients with multiple endocrine neoplasia type 1: the current evidence base.Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?Octreotide uptake in parathyroid adenoma.Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
P2860
Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effect of treatment with depot ...... plasia type 1 (MEN1) patients.
@en
Effect of treatment with depot ...... on primary hyperparathyroidism
@nl
type
label
Effect of treatment with depot ...... plasia type 1 (MEN1) patients.
@en
Effect of treatment with depot ...... on primary hyperparathyroidism
@nl
prefLabel
Effect of treatment with depot ...... plasia type 1 (MEN1) patients.
@en
Effect of treatment with depot ...... on primary hyperparathyroidism
@nl
P2093
P50
P1476
Effect of treatment with depot ...... plasia type 1 (MEN1) patients.
@en
P2093
Francesco Milone
Libuse Tauchmanova
Lidice Brandao Tavares
Maria Laura Del Basso De Caro
Valeria Ramundo
P304
P356
10.1111/J.1365-2265.2008.03301.X
P577
2008-05-14T00:00:00Z